{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-118497","form_type":"8-K","ticker":"ELDN","cik":"0001404281","company_name":"Eledon Pharmaceuticals, Inc.","filed_at":"2024-10-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.356207+00:00","generated_at":"2026-05-30T08:10:13.165517+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Eledon Pharmaceuticals prices $85M offering of common stock and pre-funded warrants at $3.65/share","bullets":["Gross proceeds ~$85M; net proceeds ~$79.5M after underwriting discounts and expenses.","Offering: 18,356,173 common shares at $3.65 plus pre-funded warrants for 4,931,507 shares at $3.649.","Investors include BVF Partners, RA Capital, Frazier Life Sciences, Blue Owl, First Light, Sphera, Woodline, Nantahala, and T1D Fund.","Proceeds to be used for advancing pipeline, working capital, and general corporate purposes.","Closing expected on or about October 30, 2024; 90-day lock-up for executives and directors."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-118497","json":"https://secwatch.observer/filing/0000950170-24-118497.json","markdown":"https://secwatch.observer/filing/0000950170-24-118497.md","text":"https://secwatch.observer/filing/0000950170-24-118497.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1404281/000095017024118497/0000950170-24-118497-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1404281/000095017024118497/eldn-20241029.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T08:10:13.165517+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}